| Literature DB >> 26904335 |
Thomas Pommepuy1, Adrien Lons1, Kevin Benad1, Eric Beltrand2, Eric Senneville3, Henri Migaud1.
Abstract
Recommendations for the management of chronic and bilateral total hip arthroplasty (THA) infection are lacking. However, this type of infection involves medical problems concerning the management of the antibiotic therapy. We report two cases of such infections operated as one-stage revision. For each case, both hips were infected with the same bacteria (Staphylococcus caprae for one patient and methicillin-sensitive Staphylococcus aureus for the other). The probabilistic antibiotic treatment started during the first side (after harvesting intraoperative samples) did not prevent the culture of the bacteriologic harvested during the intervention of the second side. Cultures were positive for the same bacteria for both sides in the two cases presented herein. After results of intraoperative cultures, patients received culture-guided antibiotic therapy for three months and were considered cured at the end of a two-year follow-up. Our results suggest one-stage bilateral change of infected THA is a viable option and that early intraoperative antibiotic, started during the first-side exchange, does not jeopardize microbiological documentation of the second side. This work brings indirect arguments, in favor of the use of prophylactic antibiotics during revision of infected THA.Entities:
Year: 2016 PMID: 26904335 PMCID: PMC4745277 DOI: 10.1155/2016/3621749
Source DB: PubMed Journal: Case Rep Orthop ISSN: 2090-6757
Figure 1(a) Preoperative AP view case 1 showing typical features of intense femoral periosteal reaction suggesting pain was related to infection. (b) Case 1 AP view at 3 years of follow-up showing regression of periosteal reaction.
Demographic, microbiological, and therapeutic data.
| Case 1 | Case 2 | |||
|---|---|---|---|---|
| Left hip | Right hip | Left hip | Right hip | |
| Date of index surgery | 2009 | 2010 | 2006 | 2009 |
| Indication for THA | Primary osteoarthritis | |||
| ASA score | 2 | 2 | ||
| CRP level at diagnosis ( | 18 mg/L | 81 mg/L | ||
| White blood cells count ( | 11700/mm3 | 12500/mm3 | ||
| Neutrophil polynuclear cells count ( | 9360/mm3 | 9850/mm3 | ||
| Date of joint aspiration | 02/11/2011 | 02/11/2011 | 02/07/2012 | 14/07/2012 |
| Bacteria at culture |
| Methicillin-sensitive | ||
| Date of 1-stage bilateral revision | 21/11/2011 | 06/08/2012 | ||
| Delay from probabilistic ATB to sample collection in the second hip | 180 minutes | 180 minutes | ||
| Probabilistic ATB | Cefepime + daptomycin | Cefotaxime + vancomycin | ||
| Culture-guided ATB debuted intravenously on day 5 for 5 days and then switched to oral for 10 weeks | Rifampicin + levofloxacin | Rifampicin + levofloxacin | ||
| Positivity of culture samples on the second side | Same bacteria | Same bacteria | ||
| CRP at the time of withdrawal of antibiotic therapy ( | 5 mg/L | 3 mg/L | ||
| Intraoperative bleeding | 1200 cc | 1600 cc | ||
| Posttreatment follow-up duration | 36 months | 24 months | ||
ATB: antibiotics therapy; CRP: C-reactive protein.